INTEGRATED PATHOLOGY PARTNERSHIPS LIMITED

Active United Kingdom

Other human health activities

223 employees website.com
Life sciences and medical technology Other human health activities
I

INTEGRATED PATHOLOGY PARTNERSHIPS LIMITED

Other human health activities

Founded 19 Mar 2010 Active United Kingdom 223 employees website.com
Life sciences and medical technology Other human health activities
Accounts Submitted 2 May 2026 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 13 Apr 2026 Next due 26 Apr 2027 11 months remaining
Net assets £5M £155K 2024 year on year
Total assets £6M £725K 2024 year on year
Total Liabilities £1M £570K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Website

www.example.com

Full company profile for INTEGRATED PATHOLOGY PARTNERSHIPS LIMITED (07195844), an active life sciences and medical technology company based in United Kingdom. Incorporated 19 Mar 2010. Other human health activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 4 months remaining

Balance Sheet & P&L (2014–2024)

Cash in Bank

N/A

Net Assets

£4.96M

Increased by £155.00k (+3%)

Total Liabilities

£1.10M

Increased by £570.00k (+107%)

Turnover

£14.28M

Increased by £937.00k (+7%)

Employees

223

Decreased by 7 (-3%)

Debt Ratio

18%

Increased by 8 (+80%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Aamisepp, RainerDirectorEstonianEstonia599 Dec 2020Active
Austin, Michael GregoryDirectorBritishUnited Kingdom5430 Apr 2025Active

Shareholders

Shareholders (1)

Labco Uk Group Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Labco Uk Group Limited

United Kingdom

Active
Notified 7 Apr 2017
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

LABCO UK GROUP LIMITED united kingdom
INTEGRATED PATHOLOGY PARTNERSHIPS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
2 May 2026AccountsAnnual accounts made up to 31 Dec 2025
13 Apr 2026Confirmation StatementConfirmation statement made on 12 Apr 2026 with no updates
22 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
2 May 2025OfficersAppointment of Mr Michael Gregory Austin as director on 30 Apr 2025
30 Apr 2025OfficersTermination of Jennifer Aikman as director on 30 Apr 2025
2 May 2026 Accounts

Annual accounts made up to 31 Dec 2025

13 Apr 2026 Confirmation Statement

Confirmation statement made on 12 Apr 2026 with no updates

22 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

2 May 2025 Officers

Appointment of Mr Michael Gregory Austin as director on 30 Apr 2025

30 Apr 2025 Officers

Termination of Jennifer Aikman as director on 30 Apr 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

3 weeks ago on 2 May 2026

Confirmation statement made on 12 Apr 2026 with no updates

1 months ago on 13 Apr 2026

Annual accounts made up to 31 Dec 2024

8 months ago on 22 Sept 2025

Appointment of Mr Michael Gregory Austin as director on 30 Apr 2025

1 years ago on 2 May 2025

Termination of Jennifer Aikman as director on 30 Apr 2025

1 years ago on 30 Apr 2025